Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
The blockbuster public offering pegs Allogene's market value at more than $2 billion. Biotech’s red-hot IPO streak shows no signs of slowing down. In fact, on Thursd.....»»
Drive-backed gene therapy startup raises $120M to amp up biotech manufacturing in Grove City
A gene therapy startup that launched last summer has raised $120 million toward expanding its biotech manufacturing capacity in Grove City. It's the largest Series B financing in Ohio history, according to PitchBook......»»
Rain Therapeutics raises $125M in 5th Bay Area life science IPO in 8 days
Rain Therapeutics Inc. was set on Friday to be the fifth Bay Area life science company in eight days to debut on Nasdaq. The Newark cancer therapeutics business raised $125 million in an initial public offering that hit the middle of its price .....»»
Explosive Bay Area biotech raises $500M in upsized IPO
The eight-year-old company has hired nearly 800 people, raised more than $870 million and plans to move into one of the East Bay's most iconic spaces as it rolls out an atypical range of products faster, cheaper and in a more environmentally safe way......»»
Arizona Gives Day raises millions to help nonprofits recover from pandemic
The annual statewide fundraiser scored $1 million more this year than in 2020, with five organizations each raising $7,500......»»
ADVAXIS MAKING BOLD STEPS IN NEW CANCER STUDIES AND AGREEMENT WITH COLUMBIA UNIVERSITY
Advaxis, Inc. (NASDAQ: ADXS), CEO Ken Berlin presented at the Benzinga Biotech Small-Cap Conference on March 24, 2021. read more.....»»
Biomea Fusion"s upsized IPO prices at top of expected range, to value the biotech at $464 million
Biomea Fusion Inc. was set to go public Friday, as the California-.....»»
Beauty biotech Amyris makes two deals with AI, Gen-Z upside
The company has invested about $12 million in acquiring and developing new brands this year, the CEO said......»»
Exclusive: Precigen"s CEO Breaks Down Biotech"s Oncology Platforms, Technology, Differentiators
Cancer treatment has evolved from the use of chemotherapeutic anti-tumor drugs to targeted therapies to monoclonal antibodies to immunotherapies to new, personalized therapeutics. read more.....»»
Biotech company spun out of Ohio State University research raises $116M in latest round
When it was founded back in 2018, Entrada raised $59 million, which was the largest amount raised in an initial financing round for an OSU startup......»»
Kintara Taking The Lead In Developing New And Innovative Rare Cancer Therapies
Kintara Therapeutics, Inc. Chief Executive Officer Saiid Zarrabian participated in the Benzinga Biotech Small Cap Conference held March 24-25, 2021. read more.....»»
The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight
Biotech stocks ended the holiday-shortened week ended April 1 in the green, catalyzed by the broader market rebound and a slew of company-specific news flow. Buoyed by hopes of a U.S. read more.....»»
Economic Report: Unemployment applications fall below 1 million for first since pandemic, but it’s no time to celebrate
The number of Americans losing their jobs each week appears to have fallen to a pandemic low, but it's no time to start popping champagne corks......»»
Armed with $72 million, startup targeting cancer expands to Durham
After a nationwide search, the company found its chief scientific officer in Durham. Now, it's expanding to the region......»»
Laryngeal Cancer Therapeutics Market To See $635M Growth By 2025 And These 2 Companies Will Be Key Drivers: Research
The global laryngeal cancer therapeutics market is expected to grow by $635.07 million during 2021-2025 helped by Amgen Inc (NASDAQ: AMGN) and AstraZeneca Plc (NYSE: AZN) as key contributors to growth, acco.....»»
Eye-popping stats about Roblox, the wildly popular game platform that"s going public Wednesday
As of September, Roblox's gaming platform had more than 30 million daily active users flocking to its mor.....»»
With pivot to cancer drug company, Peninsula biotech lines up $117M funding
The money represents only the second funding round in the company's 15 years......»»
Realtor.com: John Travolta is selling his massive waterfront mansion in Maine for $5 million
The actor John Travolta is selling his massive, oceanfront Maine mansion for $5 million. The star had owned the longtime retreat with his wife, the actress Kelly Preston, who died last year at the age of 57 of breast cancer......»»
University Hospitals building a new cancer center in NE Ohio
The $31 million, 35,000 square-foot, two-floor facility will offer both radiation and medical oncology services......»»
: Fernando Tatis Jr. to sign 14-year, $340 million megadeal with Padres: report
Fernando Tatis Jr., already one of the most exciting players in baseball, reportedly has an eye-popping contract to match......»»
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) read more.....»»